By Krissa Mou, Scarlet Park, Rakan Aqrouq, and Terry Zhang (University of British Columbia); Alvaro Aguilar De Nalda (ESADE); Utku Kaya, Omar Kanaa, Nayoung Kim, Harvey Han and Tomiwa Oshai (King’s College London) Photo: Christina Victoria Craft (Unsplash) Overview of the deal Acquirer:  Cencora Target:  OneOncology Implied Equity Value:   $6 billion Total Transaction Size:  $7.4 billion Closed date:  End of 2026 Q1 Target advisor: Debevoise & Plimpton LLP (legal) Acquirer ad